USP and Public Policy

Strengthening medicines quality systems to keep patients safe

USP advances the well-being and safety of consumers and patients by advocating for quality medicines, dietary supplements and foods. We work to promote the integrity of the global supply chain, from discovery and manufacturing to distribution and use.

At the core of our work is evidence-based outreach, advocacy and collaboration with Federal and state policy makers and other stakeholders. We also work across the globe through international policy and regulatory analysis, advocacy and collaboration with governments, multilateral institutions, regional cooperation initiatives and other stakeholder organizations.

Find USP Comment Letters, White Papers, Sign-on Letters, Testimony, Issue Briefs and Policy Positions

Search Policy Issues by Topic

Medicines Supply Chain

 

Medicines Supply Chain

 

Most Recent Policy Publications

USP Global Public Policy Position: Regulatory reform is necessary to help ensure the quality of dietary supplements

Read the PDF

USP Global Public Policy Position: Identifying and addressing vulnerabilities in the upstream medicines supply chain to build resilience and reduce drug shortages 

Read the PDF

USP Public Policy Position: Recognizing Challenges and Opportunities to Support Adoption of Advanced Manufacturing Technologies for Medical Products

Read the PDF

 

Advocacy & Correspondence

USP Statements for the Record

Submitted to the Senate Finance Committee for the Hearing: “Drug Shortages: Examining Supply Challenges, Impacts, and Policy Solutions from a Federal Health Program Perspective”

Read the PDF

USP Sign-On Letters

Mapping America’s Pharmaceutical Supply Act (the MAPS Act. H.R. 6992)

Read the PDF